Both rates and inflation are question marks. Bonds are shown in this spreadsheet to show the relative stock/bond comparison. The decision …
Sector
Among them, Exelixis, Inc. (NASDAQ:EXEL) should be at the top of the list. After a 14% fall Wednesday, EXEL stock took another beating Thursday, losing as much as 12% before closing the session down only 8%. Still, …
Trial
Investors in Exelixis Inc (Symbol: EXEL) saw new options begin trading this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EXEL options chain for the new …
NASDAQ2mon
NASDAQ
Exelixis is having an incredibly strong day in the market today after reporting positive news from a key Phase 2 clinical trial. Today, we'll talk about the data that was released, how the stock reacted to the news, and what …
Exelixis
Exelixis, Inc. (NASDAQ:EXEL) EVP Jeffrey Hessekiel sold 23,787 shares of the company’s stock in a transaction that occurred on Wednesday, March 22nd. The stock was sold at an average price of $20.54, for a total …
BNS26d
Sells
As of late, it has definitely been a great time to be an investor in Exelixis, Inc. EXEL. The stock has moved higher by 18.5% in the past month, while it is also above its 20 Day SMA too. This combination of strong price …
As such, I would not be surprised if ENZ stock’s gains stretch into triple digits by the end of 2017. #2 Best Biotech Stocks to Watch in 2017: Exelixis, Inc. (NASDAQ:EXEL) Exelixis, Inc. (NASDAQ:EXEL) is a …
SmartStockResearch.com developed a free and easy-to-use stock valuation and analysis spreadsheet, which takes a company’s financial statements and restates them in an easy-to-understand format. The spreadsheet
Here we go ladies and gents. A project that I’ve always had, was to improve on my stock portfolio tracking spreadsheets. I’ve probably used 10 or so different portfolio trackers, but nothing met my needs. I don’t do …
Stock